Fundraising Fox
Arda Therapeutics
Austin, US · Founded 2021 · Delaware corporation · 21 employees on LinkedIn · 21 known investors
Find your way into Arda Therapeutics
Sign up to see every warm intro you have to Arda Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arda Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases. The company combines drug development expertise with cellular biology to create new therapeutic approaches.
Also known as Arda · ArdaTx
Founders & leadership
Arda Therapeutics was founded in 2021 by Adam Freund and Remi-Martin Laberge.
Board
Investors · 21
How we know: age1's portfolio page · Not right? Tell us
How we know: ardatx.com · av.vc · Not right? Tell us
How we know: a16z's portfolio · board seat on SEC Form D · endpoints.news · Not right? Tell us
__Twitter.png)
How we know: ardatx.com · gaingels.com · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · ardatx.com · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: ardatx.com · manaventures.vc · Not right? Tell us
How we know: Olima Ventures's portfolio page · Not right? Tell us
How we know: RV Invest GmbH's portfolio page · Not right? Tell us
How we know: Strawberry Creek Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: ardatx.com · the VCSheet dataset · Not right? Tell us
How we know: funding news · ardatx.com · Not right? Tell us
Also in the syndicate · 7
Funding
SEC filings, press & company announcements$93.8M disclosed across 3 rounds · 2021–2024
- $43MSeries AOct 2024 · 3 sources
Andreessen Horowitz (a16z Bio + Health) (lead), Alumni Ventures, Biovision Ventures, Eli Lilly and Company, ExitFund, Gaingels, GV, Indicator Ventures, LifeLink Ventures, Mana Ventures, RV Invest, Two Sigma Ventures, Valhalla Ventures
Source ↗
▶$43.3MraisedOct 2024 · 17 investors · BiotechnologyRule 506(b)
- Vineeta AgarwalaDirector
- Adam FreundExecutive Officer, Director
- Offering amount
- $43.4M
- Amount sold
- $43.3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$7.5MraisedJan 2022 · 10 investors · BiotechnologyRule 506(b)
- Adam FreundExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $7.5M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Arda Therapeutics is a biotechnology company developing therapies aimed at chronic diseases by eliminating the pathogenic cells that drive them. Its stated approach begins with single-cell data, which it uses to identify which cell populations are pathogenic and to determine how those cells can be targeted.
The company then designs therapies intended to eliminate those specific cells while sparing others, framing cells as both the functional units of life and of disease.
▸Full profile — market position, technology
Market position
Arda operates in therapeutics for chronic disease, with a cell-elimination approach rather than a conventional pathway- or symptom-directed strategy.
Technology
Arda's platform is built on single-cell data analysis, used first to identify pathogenic cell populations and the targeting handles that distinguish them, and then to design therapies that selectively eliminate those cells and only those cells.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Related companies · 6
Companies working in the same space as Arda Therapeutics.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- Arda Therapeuticsardatx.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Arda Therapeutics do?
- Arda Therapeutics uses single-cell data to design therapies that eliminate the pathogenic cells driving chronic diseases.
- Who founded Arda Therapeutics?
- Arda Therapeutics was founded by Adam Freund, Remi-Martin Laberge in 2021.
- Who are Arda Therapeutics's investors?
- Arda Therapeutics's investors include age1, Alumni Ventures, Andreessen Horowitz, Gaingels, GV (Google Ventures), Lifelink, Mana Ventures, Olima Ventures and 6 more.
- How much funding has Arda Therapeutics raised?
- Arda Therapeutics has disclosed $93.8M raised across 3 rounds.
- Where is Arda Therapeutics headquartered?
- Arda Therapeutics is headquartered in Austin, US.